Wilshire Pharmaceuticals Inc: Drug Recall
Recall #D-0259-2021 · 02/04/2021
Class II: Risk
Recall Details
- Recall Number
- D-0259-2021
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Wilshire Pharmaceuticals Inc
- Status
- Terminated
- Date Initiated
- 02/04/2021
- Location
- Atlanta, GA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 35928 bottles
Reason for Recall
Failed Dissolution Specifications
Product Description
Meclizine HCl Tablets, USP, 25 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328, Product of India, NDC 52536-133-01
Distribution Pattern
FL, TX
Other Recalls by Wilshire Pharmaceuticals Inc
- Class II: Risk 02/04/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.